Developer docs
API playgroundTry for free, no card

Search company profiles

ElastiMed

Full company profile

uuid00046i6

Namestring
ElastiMed
Legal namestring
Elastimed Ltd.
Websiteurl
elastimed.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

ElastiMed Ltd. is an Israel-based medical device company founded in 2015 that develops wearable smart compression therapy devices for the treatment of chronic lymphatic and venous conditions. Its flagship product, MyoSleeve, is an FDA 510(k)-cleared, cable-free, battery-powered compression garment for the lower leg that uses proprietary Electroactive Polymer (EAP) technology—marketed as 'Artificial Muscles'—to deliver dynamic, sequential compression therapy mimicking manual lymphatic drainage. Three built-in straps contract in sequence to stimulate blood and lymphatic flow, with a cycle repeating every 15 seconds; the device provides up to 8 hours of active treatment per charge and maintains static resting compression when powered off.

The company targets patients with lymphedema, chronic edema, and chronic venous insufficiency, as well as clinicians in vascular surgery, phlebology, and vein care. MyoSleeve is currently distributed exclusively in the United States through Tactile Medical (Nasdaq: TCMD) under a July 2026 agreement covering Veterans Affairs (VA) and Department of Defense (DoD) healthcare systems, with Tactile Medical making a $3 million upfront payment and committing to minimum purchase obligations. ElastiMed employs approximately 10 people across its Yokneam Ilit, Israel headquarters and US subsidiary in Jericho, NY, and is backed by portfolio investor Trendlines Group Ltd. The company has raised approximately $3.66 million across disclosed funding rounds (2015–2018) and is led by founder/CEO Omer Zelka with Chairman Dr. Amir Belson, a serial medtech entrepreneur with prior exits to Intuitive Surgical, C.R. Bard, and Stryker.

Short descriptiontext

ElastiMed is an Israel-based medical device company that develops MyoSleeve, a cable-free wearable compression device using proprietary electroactive polymer technology to treat lymphedema and chronic venous conditions, distributed in the US through Tactile Medical for VA and DoD patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersYoqne`am `illit, Israel
HQ citystring
Yoqne`am `illit
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wearable compression therapy, medical device manufacturing, lymphedema treatment devices, electroactive polymer technology, vascular compression devices
Industry1 code
PRIMARYHLAHALAF
Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Wearable Compression Therapy Devices
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Hardware Device Sales via Distribution Partners
TypeHardware Sales
Description

ElastiMed sells MyoSleeve devices to distribution partners (Tactile Medical) who then distribute to end customers (VA/DoD patients). Tactile Medical made an upfront payment of $3 million and commits to minimum purchase obligations in exchange for exclusive distribution rights.

stocktitan.net
2Recurring Hardware Revenue
TypeHardware Sales
Description

Post-initial commercialization, recurring hardware/device revenue is expected from ongoing device sales through Tactile Medical's exclusive distribution agreement covering VA and DoD systems.

elastimed.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1MyoSleeve prescription medical device — pricing not publicly disclosed
ModelOtherBilling cadencePay-as-you-go
Notes

Available by prescription. End-customer pricing not publicly disclosed. Tactile Medical (distributor) manages billing and payment under its established infrastructure.

elastimed.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1MyoSleeve
Description

FDA-cleared cable-free wearable compression device for lower leg treatment of lymphedema and venous conditions using electroactive polymer technology.

elastimed.com
Core offering1 text field

ElastiMed manufactures and sells MyoSleeve, a cable-free, battery-powered wearable compression device for the lower leg that uses proprietary electroactive polymer (EAP) technology to deliver sequential dynamic compression therapy for patients with lymphedema, chronic edema, and venous insufficiency. The FDA 510(k)-cleared device delivers up to 8 hours of active treatment per charge, mimicking manual lymphatic drainage through three sequential straps that massage the calf every 15 seconds. The product is available by prescription and currently distributed through an exclusive US partnership with Tactile Medical for VA and DoD patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Statistically significant volume reduction in lower leg after just 4 hours of use compared to standard compression bandages in clinical studies
Product overview1 text field

ElastiMed is a single-product company focused on MyoSleeve, an FDA-cleared wearable compression device that uses proprietary electroactive polymer (EAP) technology marketed as 'Artificial Muscles.' The device is designed for the lower leg and provides active therapeutic compression for lymphatic and venous conditions. The company is reportedly developing future models for full-leg and arm applications. All offerings center on this one device, which is available by prescription and distributed through the exclusive Tactile Medical partnership for VA and DoD markets.

Product and service1 record
1MyoSleeve
CategoryWearable Compression Therapy Device
Description

FDA 510(k)-cleared, cable-free, battery-powered wearable compression device for the lower leg that uses proprietary electroactive polymer (EAP) technology to deliver dynamic compression through three sequential straps that contract in sequence, mimicking manual lymphatic drainage. Indicated for treatment of chronic swelling including lymphedema, chronic edema, and venous insufficiency. Available by prescription and distributed through the exclusive Tactile Medical partnership for VA and DoD markets.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-07-13
Description

Tactile Medical signed an exclusive US distribution agreement with ElastiMed for MyoSleeve covering VA and DoD patients. Tactile Medical made an upfront payment of $3 million and committed to minimum purchase obligations in exchange for exclusive distribution rights within the VA and DoD systems. This represents the first commercial introduction of MyoSleeve. Tactile Medical leverages its established sales organization, billing and payment expertise, and patient support infrastructure to drive commercialization and market access. MyoSleeve is available by prescription, with patient selection determined by treating clinicians.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US manufacturer of pneumatic compression pumps and sleeves for lymphedema, venous insufficiency, and wound healing. Directly competes with MyoSleeve in clinical-grade compression therapy for the same patient populations.

TypeBroad incumbent
Description

German manufacturer of medical compression stockings, sleeves, and orthopedic supports for lymphedema and venous conditions. Comparable target indications but with a static-garment product focus rather than powered wearables.

TypeBroad incumbent
Description

Global medical device company providing DVT prevention systems (Flowtron), patient lifts, and pressure injury prevention solutions. Overlapping in compression therapy for venous thromboembolism prevention in clinical settings.

TypeBroad incumbent
Description

Established global manufacturer of medical compression garments (stockings, socks, sleeves) for venous and lymphatic disease. A leader in compression therapy but focused on passive garments rather than active electro-mechanical devices.

TypeOthers
Description

Large diversified medical device company; relevant as the acquirer of Zipline Medical (founded by ElastiMed's Chairman Dr. Amir Belson). Strategic acquirer profile for medical device companies with proven commercial traction in niche therapy areas.

TypeBroad incumbent
Description

Global medical device company offering a broad portfolio including medical compression stockings, intermittent pneumatic compression devices (IPC), and orthopedic braces. Overlapping in compression therapy for venous and lymphatic conditions but with a much wider product portfolio.

TypeDirect peer
Description

NASDAQ-listed leader in pneumatic compression pumps for lymphedema and venous conditions. Tactile Medical is both ElastiMed's exclusive US distributor for VA/DoD and a competitor via its Entré/Flexitouch pneumatic pump lines, making it the closest comparable for compression therapy market dynamics.

TypeEmerging player
Description

Consumer/recovery-focused brand best known for NormaTec pneumatic compression boots used by athletes and increasingly in wellness/clinical settings. Comparable compression therapy technology but skewed toward consumer/recovery rather than prescription chronic-disease use.

TypeDirect peer
Description

Specializes in compression therapy devices including pneumatic pumps and DVT prevention systems, serving lymphedema and chronic venous insufficiency patients with comparable clinical-grade compression solutions.

TypeDirect peer
Description

Manufacturer of pneumatic compression devices (Armassist, Legassist) and compression therapy garments for lymphedema and venous disease. Closely comparable therapeutic area and delivery modality (compression therapy).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ElastiMed

Wearable Compression Therapy Deviceselastimed.com

ElastiMed is an Israel-based medical device company that develops MyoSleeve, a cable-free wearable compression device using proprietary electroactive polymer technology to treat lymphedema and chronic venous conditions, distributed in the US through Tactile Medical for VA and DoD patients.

What ElastiMed does

ElastiMed Ltd. is an Israel-based medical device company founded in 2015 that develops wearable smart compression therapy devices for the treatment of chronic lymphatic and venous conditions. Its flagship product, MyoSleeve, is an FDA 510(k)-cleared, cable-free, battery-powered compression garment for the lower leg that uses proprietary Electroactive Polymer (EAP) technology—marketed as 'Artificial Muscles'—to deliver dynamic, sequential compression therapy mimicking manual lymphatic drainage. Three built-in straps contract in sequence to stimulate blood and lymphatic flow, with a cycle repeating every 15 seconds; the device provides up to 8 hours of active treatment per charge and maintains static resting compression when powered off.

The company targets patients with lymphedema, chronic edema, and chronic venous insufficiency, as well as clinicians in vascular surgery, phlebology, and vein care. MyoSleeve is currently distributed exclusively in the United States through Tactile Medical (Nasdaq: TCMD) under a July 2026 agreement covering Veterans Affairs (VA) and Department of Defense (DoD) healthcare systems, with Tactile Medical making a $3 million upfront payment and committing to minimum purchase obligations. ElastiMed employs approximately 10 people across its Yokneam Ilit, Israel headquarters and US subsidiary in Jericho, NY, and is backed by portfolio investor Trendlines Group Ltd. The company has raised approximately $3.66 million across disclosed funding rounds (2015–2018) and is led by founder/CEO Omer Zelka with Chairman Dr. Amir Belson, a serial medtech entrepreneur with prior exits to Intuitive Surgical, C.R. Bard, and Stryker.

ElastiMed firmographics

Firmographics
Name
ElastiMed
Legal name
Elastimed Ltd.
Website
https://elastimed.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
ElastiMed is an Israel-based medical device company that develops MyoSleeve, a cable-free wearable compression device using proprietary electroactive polymer technology to treat lymphedema and chronic venous conditions, distributed in the US through Tactile Medical for VA and DoD patients.
Ownership category
akta.pro rank

ElastiMed industry classification

Industry
Product category
Wearable Compression Therapy Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHALAF
Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products

Keywords

  • Wearable compression therapy
  • Medical device manufacturing
  • Lymphedema treatment devices
  • Electroactive polymer technology
  • Vascular compression devices

Where ElastiMed is headquartered

Location

Headquarters

HQ city
Yoqne`am `illit
HQ country
Israel
HQ region
Middle East

Offices2 records

Markets served

ElastiMed business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Hardware Device Sales via Distribution Partners: ElastiMed sells MyoSleeve devices to distribution partners (Tactile Medical) who then distribute to end customers (VA/DoD patients). Tactile Medical made an upfront payment of $3 million and commits to minimum purchase obligations in exchange for exclusive distribution rights.
  2. Recurring Hardware Revenue: Post-initial commercialization, recurring hardware/device revenue is expected from ongoing device sales through Tactile Medical's exclusive distribution agreement covering VA and DoD systems.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goMyoSleeve prescription medical device — pricing not publicly disclosed

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

ElastiMed product offering

Product offering

Core offering

ElastiMed manufactures and sells MyoSleeve, a cable-free, battery-powered wearable compression device for the lower leg that uses proprietary electroactive polymer (EAP) technology to deliver sequential dynamic compression therapy for patients with lymphedema, chronic edema, and venous insufficiency. The FDA 510(k)-cleared device delivers up to 8 hours of active treatment per charge, mimicking manual lymphatic drainage through three sequential straps that massage the calf every 15 seconds. The product is available by prescription and currently distributed through an exclusive US partnership with Tactile Medical for VA and DoD patients.

Product overview

ElastiMed is a single-product company focused on MyoSleeve, an FDA-cleared wearable compression device that uses proprietary electroactive polymer (EAP) technology marketed as 'Artificial Muscles.' The device is designed for the lower leg and provides active therapeutic compression for lymphatic and venous conditions. The company is reportedly developing future models for full-leg and arm applications. All offerings center on this one device, which is available by prescription and distributed through the exclusive Tactile Medical partnership for VA and DoD markets.

Differentiator

Problem solved

Functional benefit

Brands

  • MyoSleeve: FDA-cleared cable-free wearable compression device for lower leg treatment of lymphedema and venous conditions using electroactive polymer technology.

Products and services

  • MyoSleeve FDA 510(k)-cleared, cable-free, battery-powered wearable compression device for the lower leg that uses proprietary electroactive polymer (EAP) technology to deliver dynamic compression through three sequential straps that contract in sequence, mimicking manual lymphatic drainage. Indicated for treatment of chronic swelling including lymphedema, chronic edema, and venous insufficiency. Available by prescription and distributed through the exclusive Tactile Medical partnership for VA and DoD markets.

Quantifiable outcome

  • Statistically significant volume reduction in lower leg after just 4 hours of use compared to standard compression bandages in clinical studies

Companies that use ElastiMed

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

ElastiMed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

ElastiMed partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Tactile Medical (Tactile Systems Technology, Inc.)flagshipChannel Partner/ Reseller/ Distributor · 13 July 2026Tactile Medical signed an exclusive US distribution agreement with ElastiMed for MyoSleeve covering VA and DoD patients. Tactile Medical made an upfront payment of $3 million and committed to minimum purchase obligations in exchange for exclusive distribution rights within the VA and DoD systems. This represents the first commercial introduction of MyoSleeve. Tactile Medical leverages its established sales organization, billing and payment expertise, and patient support infrastructure to drive commercialization and market access. MyoSleeve is available by prescription, with patient selection determined by treating clinicians.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

ElastiMed competitors and assessment

Company assessment

Direct peers

  • Bio Compression Systems: US manufacturer of pneumatic compression pumps and sleeves for lymphedema, venous insufficiency, and wound healing. Directly competes with MyoSleeve in clinical-grade compression therapy for the same patient populations.
  • Tactile Medical: NASDAQ-listed leader in pneumatic compression pumps for lymphedema and venous conditions. Tactile Medical is both ElastiMed's exclusive US distributor for VA/DoD and a competitor via its Entré/Flexitouch pneumatic pump lines, making it the closest comparable for compression therapy market dynamics.
  • Devon Medical Products: Specializes in compression therapy devices including pneumatic pumps and DVT prevention systems, serving lymphedema and chronic venous insufficiency patients with comparable clinical-grade compression solutions.
  • AIROS Medical: Manufacturer of pneumatic compression devices (Armassist, Legassist) and compression therapy garments for lymphedema and venous disease. Closely comparable therapeutic area and delivery modality (compression therapy).

Broad incumbents

  • Juzo (Julius Zorn GmbH): German manufacturer of medical compression stockings, sleeves, and orthopedic supports for lymphedema and venous conditions. Comparable target indications but with a static-garment product focus rather than powered wearables.
  • Arjo (Getinge Group): Global medical device company providing DVT prevention systems (Flowtron), patient lifts, and pressure injury prevention solutions. Overlapping in compression therapy for venous thromboembolism prevention in clinical settings.
  • SIGVARIS Group: Established global manufacturer of medical compression garments (stockings, socks, sleeves) for venous and lymphatic disease. A leader in compression therapy but focused on passive garments rather than active electro-mechanical devices.
  • medi GmbH & Co. KG: Global medical device company offering a broad portfolio including medical compression stockings, intermittent pneumatic compression devices (IPC), and orthopedic braces. Overlapping in compression therapy for venous and lymphatic conditions but with a much wider product portfolio.

Others

  • Stryker: Large diversified medical device company; relevant as the acquirer of Zipline Medical (founded by ElastiMed's Chairman Dr. Amir Belson). Strategic acquirer profile for medical device companies with proven commercial traction in niche therapy areas.

Emerging players

  • Hyperice (NormaTec): Consumer/recovery-focused brand best known for NormaTec pneumatic compression boots used by athletes and increasingly in wellness/clinical settings. Comparable compression therapy technology but skewed toward consumer/recovery rather than prescription chronic-disease use.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

ElastiMed social profiles

Digital presence

ElastiMed compliance and trust

Trust signal

Compliance1 record

ElastiMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ElastiMed leadership team

Management profile

Number of profiles

Profiles17 records

ElastiMed funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ElastiMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ElastiMed

What does ElastiMed do?

ElastiMed manufactures and sells MyoSleeve, a cable-free, battery-powered wearable compression device for the lower leg that uses proprietary electroactive polymer (EAP) technology to deliver sequential dynamic compression therapy for patients with lymphedema, chronic edema, and venous insufficiency. The FDA 510(k)-cleared device delivers up to 8 hours of active treatment per charge, mimicking manual lymphatic drainage through three sequential straps that massage the calf every 15 seconds. The product is available by prescription and currently distributed through an exclusive US partnership with Tactile Medical for VA and DoD patients.

Is ElastiMed a public or private company?

ElastiMed is a private company. It is classified as venture growth investor backed and is currently operating.

When was ElastiMed founded?

ElastiMed was founded in 2015. It employs 11 to 50 people.

Where is ElastiMed based?

ElastiMed is headquartered in Yoqne`am `illit, Israel, in the Middle East region.

How does ElastiMed make money?

Two revenue lines are on record. Hardware Device Sales via Distribution Partners are the primary driver. The others are recurring Hardware Revenue.

Who are ElastiMed's main competitors?

Direct peers on record are Bio Compression Systems, Tactile Medical, Devon Medical Products and AIROS Medical. Broad incumbents are Juzo (Julius Zorn GmbH), Arjo (Getinge Group), SIGVARIS Group and medi GmbH & Co. KG. Stryker is listed as an others. Hyperice (NormaTec) is listed as an emerging player.

Does ElastiMed have an API?

No public API is recorded for ElastiMed.

What industry is ElastiMed in?

ElastiMed's product category is Wearable Compression Therapy Devices. Its primary akta.pro industry code is HLAHALAF, Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Stock TitanTactile Medical Q2 Earnings: Revenue Up 9% to $85.7MTactile Systems Technology, Inc. reported second quarter 2026 financial results with total revenue of $85.7 million, representing 9% year-over-year growth driven by a 12% increase in lymphedema product line sales. The company posted net income of $7.8 million and adjusted EBITDA of $11.4 million, both more than doubling from the prior year period, while expanding gross margin to 76%. The company also announced an exclusive distribution agreement with ElastiMed, Inc. for MyoSleeve, commercially launched its next-generation AffloVest system, and updated full-year 2026 revenue guidance to $360-366 million.MarketScreenerTrendlines Portfolio Company ElastiMed Signs US Distribution DealTrendlines Group Ltd., an Israel-based life sciences innovation commercialization company, announced that its portfolio company ElastiMed has signed a distribution deal in the United States. The deal will enable ElastiMed's medical technology products to reach the US market through a distribution partner. Trendlines Group manages over 50 portfolio companies across medical and agricultural technology sectors through its various incubator units.Stock TitanTactile Medical inks exclusive VA, DoD MyoSleeve dealTactile Medical has entered into an exclusive U.S. distribution agreement with ElastiMed for MyoSleeve, a wearable non-pneumatic compression device for lower-leg chronic swelling conditions, covering VA and DoD patients. Tactile Medical made an upfront payment of $3 million and committed to minimum purchase obligations in exchange for exclusive distribution rights within the VA and DoD systems. The partnership represents the first commercial introduction of MyoSleeve, which uses electroactive polymer technology and has received FDA 510(k) clearance.PR NewswireElastiMed Appoints Dr. Steve Elias to its Medical Advisory BoardElastiMed Ltd., a Yokneam, Israel-based wearable medical device company, announced the appointment of Dr. Steve Elias to its Medical Advisory Board. Dr. Elias brings board certification in venous and lymphatic medicine along with experience in vascular surgery, serving as Director of the Center for Vein Disease at Englewood Health Network. The appointment is intended to guide ElastiMed's product development and reinforce the company's focus on wearable compression technology for treating lymphatic and venous diseases.PR NewswireElastiMed Welcomes Dr. Amir Belson as a Member of the Board of DirectorsElastiMed Ltd., a Yokneam, Israel-based wearable medical device company focused on lymphatic and venous disease treatment, announced the appointment of Dr. Amir Belson to its Board of Directors. Dr. Belson brings extensive experience in the medical device industry, having founded multiple companies that were successfully acquired by major players including Intuitive Surgical, C.R. Bard, and Stryker. The appointment is intended to support ElastiMed's next phase of growth as it works to bring its wearable medical devices to market.GlobesSmart medical sock co Elastimed awarded $1.6m EU grantElastimed, an Israeli smart medical sock company, received a $1.6 million grant from the EU's Horizon 2020 program. The funds will support product development, clinical studies, production scale-up, marketing, and expanding intellectual property. The company's device uses electric pulses to improve leg circulation for venous and lymphatic diseases.PR NewswireElastiMed Chosen by Horizon 2020 to Receive US$1.6M GrantElastiMed Ltd., an Israeli medical device company, was selected to receive a US$1.6 million grant from the Horizon 2020 program under the European Innovation Council (EIC) pilot. The two-year grant will fund further product development, clinical studies, production scale-up, marketing, and expansion of the company's intellectual property for its wearable compression device that treats venous and lymphatic diseases. The funding represents a strategic milestone for ElastiMed, founded in 2015, as it works toward bringing its product to market to address a potential worldwide market estimated at US$3.3 billion.The Jerusalem PostIsraeli firm launches circulation-stimulating smart socksIsraeli start-up Elastimed launched smart socks that use smart materials to stimulate blood circulation in legs. The device applies electrical pulses to compress the leg, offering an alternative to compression socks, which studies show only one in five patients of chronic venous disease use daily. Sales are expected to begin by mid-2019.PR NewswireElastiMed Secures Additional US$1 Million in FundingElastiMed Ltd., an Israeli medical device company, has raised US$1 million in additional funding from strategic and existing investors, including The Trendlines Group, Pix Vine Capital, and the Israeli Innovation Authority, bringing its total funding to US$2 million. The funds will support clinical studies, regulatory filings, and expansion of intellectual property for the company's wearable medical device designed to improve leg circulation for treating venous and lymphatic diseases. The company addresses a potential worldwide market of US$3.3 billion and highlights a greater than 60% non-compliance rate with existing treatment options.FinSMEsElastiMed Raises $1M in Venture Capital FundingElastiMed, an Israeli developer of a smart-material wearable for treating chronic venous insufficiency and preventing DVT, raised $1M in funding from Pix Vine Capital. The company will use the funds to complete R&D, proceed with regulatory filings, and commence clinical trials.